|
|
Strategic Prevention Framework Partnerships For Success II (SPF PFS II)What is the Strategic Prevention Framework (SPF)?The SPF is a SAMHSA-wide planning model for prevention that is relevant for substance abuse, mental health promotion, and other prevention areas. It incorporates the collection and use of data at all steps and requires that throughout the process, cultural competency and sustainability of efforts are addressed. It consists of five basic steps:
As can been seen in Figure 1 to the right, these steps are part of a circular process. Beginning with the assessment, States must first conduct a state-wide needs assessment of indicators and outcomes of substance use including alcohol, tobacco, and other drugs (ATOD). Next the building of capacity at the state level is required, then the development of a strategic plan to address the priorities, the implementation of the plan, and finally the evaluation. As with most processes, however, some of these steps may occur simultaneously with other steps. For example, capacity building may occur while the needs assessment is also occurring or the planning is occurring. Data are used throughout to drive both the focus of prevention efforts and the types of prevention effort. Both the process and the outcome are important and data are to be used to direct, modify, and assess efforts through out the process. What is the SPF PFS II Grant?The Wisconsin Strategic Prevention Framework Partnership for Success II Project (SPF PFS II) is focused on the prevention priority: Prescription drug misuse and abuse among persons aged 12-25. Evidence-based prevention efforts for reducing problems related to the non-medical use of prescription drugs will be funded in eight high need counties and one high need tribe and will focus on reducing youth/young adult access to and the availability of prescription drugs in the community. These sub-grantees were identified by weighting risk-factor data measures (Medicaid Lock-In program participants in the past 12 months, Medicaid controlled substances prescriptions written in the past 6 months and treatment for depression and anxiety among 12-25 year olds in the past 12 months) and consequence data measures (School suspensions/expulsions, juvenile drug arrests, hospitalization admits for prescription drug issues among 12-25 year olds in the past 12 months, treatment for prescription drug issues among 12-25 year olds in the past 12 months, and drug-related motor vehicle fatalities) against the total county population. Wisconsin’s identified nine sub-grantees are primarily clustered into two regions; northern and southeastern Wisconsin, with one county located in central Wisconsin. The overall population of sub-recipient counties is close to 1.5 million with a 12-25 year population of nearly 300,000. Overall, the population of these communities is 68% white, 20% African American, 12 % Hispanic and 1% Native American. Seventeen percent of this population lives below the poverty level. Brief description of PFS II Project in Wisconsin: Wisconsin is using a comprehensive evidence-based prevention
approach focusing on two goals: 1) Reduce the non-medical/unauthorized
availability of and access to prescription drugs among 12-25 year olds within
sub-recipient geographic areas; and 2) Establish a statewide systematic
surveillance system to identify prescription
In order to achieve these goals, Wisconsin has identified six measurable objectives: 1) Raise awareness among parents, youth, patients, and healthcare providers; 2) Increase sub-recipient’s surveillance system capacity in order to identify and track emerging prescription drug-related trends; 3) Increase the proper disposal of expired and unused prescription drugs in sub-recipient communities; 4) Enhance law enforcement’s capacity to address unauthorized prescription drug use by building bridges between law enforcement and community-based prescription drug misuse and abuse prevention efforts.; 5) Increase the availability of disaggregated data; and 6) Increase collaborative efforts among state departments and local county/tribal service agencies in order to align relevant prescription drug information into a state-wide surveillance system. Wisconsin will address these objectives by implementing the following six strategies:
PFS II MaterialsWI SPF PFS II Federal Application Narrative regarding SAMHSA RFA SP-12-004 July, 2012. Wisconsin County Prescription Drug Abuse Risk and Consequence Data Table - data used to rank Wisconsin's 72 counties on prescription drug risk and consequence indicators. Wisconsin DRE Evaluation Reports 2007-2011 - Evaluation reports for Wisconsin Drug Recognition Experts from 2007-2011 SPF PFS II Resource Links on the BPTR Links webpage. Grantee Deliverables and Materials
Staff Contacts:Email is the preferred method of contact Christine Niemuth Louis Oppor Last Revised: March 25, 2013 |